ArticlePediatric nephrology (Berlin, Germany)2025

Toward lean body weight- and ECV-based dosing of burosumab: eliminating apparent sex differences in XLH therapy.

Guido Filler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.